Top Buy
| Security | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Neurocrine Bioscience | 27 | 0 | 4 | 0 | €130.70 | €140.34 | 7.376% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €20.62 | €26.01 | 26.122% |
| Merit Medical Systems | 16 | 0 | 3 | 0 | €70.50 | €86.90 | 23.258% |
| United Therapeutics | 18 | 0 | 3 | 0 | €243.70 | €288.66 | 18.449% |
| Jazz Pharmaceuticals plc | 23 | 0 | 3 | 0 | €102.25 | €184.92 | 80.851% |
| LivaNova plc | 9 | 0 | 2 | 0 | €57.00 | €66.59 | 16.829% |
| Bio-Techne Corp. | 10 | 0 | 2 | 0 | €72.00 | €75.94 | 5.467% |
| PTC Therapeutics Inc. | 14 | 5 | 2 | 0 | €31.00 | €41.51 | 33.911% |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 1 | 0 | €39.80 | €84.74 | 112.925% |
| Repligen Corp. | 13 | 0 | 1 | 0 | €155.15 | €184.76 | 19.085% |
| Korian S.A. | 1 | 0 | 1 | 0 | €2.39 | - | - |
| Masimo Corp. | 7 | 1 | 1 | 0 | €127.05 | €147.62 | 16.187% |
| Uniqure B.V. | 1 | 0 | 1 | 0 | €4.24 | - | - |
| Alnylam Pharmace. | 36 | 0 | 1 | 0 | €141.60 | €228.30 | 61.229% |
| Halozyme Therapeutics Inc. | 13 | 0 | 1 | 0 | €37.15 | €53.50 | 43.998% |
| Myriad Genetics | 5 | 2 | 0 | 0 | €18.10 | €23.22 | 28.273% |
| Amedisys Inc. | 13 | 0 | 0 | 0 | €84.00 | €92.26 | 9.833% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €66.75 | €65.00 | -2.622% |
| Ensign Group Inc. | 8 | 0 | 0 | 0 | €109.00 | €116.50 | 6.877% |
| Icon plc | 18 | 0 | 0 | 0 | €280.90 | €319.67 | 13.802% |
| Horizon Pharma plc | 7 | 0 | 0 | 0 | €110.40 | - | - |
| Agios Pharmaceuticals Inc. | 5 | 0 | 0 | 0 | €30.60 | €38.99 | 27.414% |
| Xencor Inc. | 9 | 1 | 0 | 0 | €18.70 | €31.74 | 69.727% |
| Healthequity Inc. | 1 | 0 | 0 | 0 | €73.50 | €79.00 | 7.483% |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | €128.00 | €150.00 | 17.188% |